MannKind (MNKD) in Focus: Stock Rises 10.1% in Session - Tale of the Tape
MannKind Corp. (MNKD) was a big mover last session, as the company saw its shares rise more than 10% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the company as the stock is now down 10.75% in the past one-month time frame.
This med-biomed/gene stock witnessed one negative estimate revision and three positive estimate revisions over the past 30 days. The Zacks Consensus Estimate also moved up over the same time frame, suggesting that more solid trading could be ahead for MannKind. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.
MannKind has a Zacks Rank #3 (Hold).
However, a better-ranked stock in the same space is Actelion Ltd. (ALIOF), sporting a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
MANNKIND CORP (MNKD): Free Stock Analysis Report
ACTELION LTD (ALIOF): Free Stock Analysis Report
To read this article on Zacks.com click here.
